The waiting time for the result is only 4 weeks

The analysis always includes genetic changes within exons, introns and promoters of genes and in mitochondrial DNA

Always an additional test included in the price

Consultation with specialist and written interpretation of the result

Each result is reanalysed every 6 months .

Rough data from sequencing are made available on request.

Short or long QT syndromes 

connected with ventricular arrhythmias.

The syndrome may be diagnosed on the basis of EKG, however genetic tests may be helpful.

Brugada Syndrome - is a heart disease which is genetic.

Most often it appears in the form of ventricular tachycardia, which can lead to ventricular fibrillation and, consequently, to death.

The prevalence of Brugada syndrome in the general population worldwide is estimated at 5 to 20 cases per 10,000 people.

The greatest prevalence is observed among the inhabitants of Southeast Asia.

The most common symptoms are: ♦ dizziness, ♦ fainting, ♦ heavy breathing, especially at night, ♦ irregular heartbeat or palpitations, ♦ niezwykle szybkie i haotyczne bicie serca, ♦ seizures.

Brugada syndrome is believed to be responsible for 4-12% of cases of sudden cardiac death in general

and for 20% of cases of sudden cardiac death in people without organic heart disease 

Risk factors: ♦ genetic load, ♦ male gender, ♦ asian race.

Test covers the analysis of 73165 zmian genetycznych (SNP) w 132 genes:

Ostatnia aktualizacja bazy: 2023.12.23